Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
36.90
-0.44 (-1.18%)
Aug 20, 2025, 3:02 PM - Market open
Surmodics Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2016 - 2020 |
| 120.8 | 126.08 | 132.58 | 99.95 | 105.14 | 94.86 | Upgrade | |
Revenue Growth (YoY) | -0.02% | -4.91% | 32.65% | -4.93% | 10.83% | -5.21% | Upgrade |
Cost of Revenue | 28.73 | 33.03 | 24.97 | 20.34 | 17.68 | 65.51 | Upgrade |
Gross Profit | 92.07 | 93.05 | 107.62 | 79.61 | 87.46 | 29.36 | Upgrade |
Selling, General & Admin | 51.65 | 53.14 | 51.88 | 46.94 | 31.58 | 28.39 | Upgrade |
Research & Development | 38.36 | 38.36 | 46.6 | 50.61 | 48.93 | - | Upgrade |
Operating Expenses | 93.52 | 95 | 102.02 | 101.69 | 83.3 | 30.61 | Upgrade |
Operating Income | -1.45 | -1.95 | 5.6 | -22.09 | 4.16 | -1.25 | Upgrade |
Interest Expense | -3.49 | -3.54 | -3.49 | -0.6 | -0.31 | -0.13 | Upgrade |
Interest & Investment Income | 1.34 | 1.92 | 1.08 | 0.1 | 0.12 | 0.66 | Upgrade |
Currency Exchange Gain (Loss) | -0.2 | -0.24 | -0.25 | 0.1 | -0.17 | -0.25 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | - | - | 0 | Upgrade |
EBT Excluding Unusual Items | -3.79 | -3.81 | 2.94 | -22.48 | 3.8 | -0.98 | Upgrade |
Merger & Restructuring Charges | -10.9 | -3.7 | -1.28 | - | -1.05 | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.48 | Upgrade |
Other Unusual Items | - | - | 0.83 | -0.01 | 3.6 | - | Upgrade |
Pretax Income | -14.69 | -7.51 | 2.49 | -22.49 | 6.35 | -1.45 | Upgrade |
Income Tax Expense | 2.94 | 4.04 | 4.02 | 4.78 | 2.11 | -2.58 | Upgrade |
Earnings From Continuing Operations | -17.63 | -11.54 | -1.54 | -27.27 | 4.24 | 1.12 | Upgrade |
Net Income | -17.63 | -11.54 | -1.54 | -27.27 | 4.24 | 1.12 | Upgrade |
Net Income to Common | -17.63 | -11.54 | -1.54 | -27.27 | 4.24 | 1.12 | Upgrade |
Net Income Growth | - | - | - | - | 277.29% | -85.21% | Upgrade |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 14 | Upgrade |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 | Upgrade |
Shares Change (YoY) | 0.87% | 0.87% | 0.83% | -0.52% | 1.28% | 0.24% | Upgrade |
EPS (Basic) | -1.24 | -0.82 | -0.11 | -1.96 | 0.31 | 0.08 | Upgrade |
EPS (Diluted) | -1.24 | -0.82 | -0.11 | -1.96 | 0.30 | 0.08 | Upgrade |
EPS Growth | - | - | - | - | 275.00% | -85.45% | Upgrade |
Free Cash Flow | -3.55 | -3.24 | 7.6 | -20.59 | 10.11 | 10.34 | Upgrade |
Free Cash Flow Per Share | -0.25 | -0.23 | 0.54 | -1.48 | 0.72 | 0.75 | Upgrade |
Gross Margin | 76.22% | 73.80% | 81.17% | 79.65% | 83.19% | 30.95% | Upgrade |
Operating Margin | -1.20% | -1.54% | 4.23% | -22.10% | 3.95% | -1.32% | Upgrade |
Profit Margin | -14.59% | -9.16% | -1.16% | -27.29% | 4.03% | 1.18% | Upgrade |
Free Cash Flow Margin | -2.94% | -2.57% | 5.73% | -20.60% | 9.62% | 10.90% | Upgrade |
EBITDA | 7.02 | 6.75 | 14.13 | -12.94 | 12.17 | 6.01 | Upgrade |
EBITDA Margin | 5.81% | 5.35% | 10.65% | -12.95% | 11.58% | 6.34% | Upgrade |
D&A For EBITDA | 8.46 | 8.69 | 8.52 | 9.14 | 8.02 | 7.26 | Upgrade |
EBIT | -1.45 | -1.95 | 5.6 | -22.09 | 4.16 | -1.25 | Upgrade |
EBIT Margin | -1.20% | -1.54% | 4.23% | -22.10% | 3.95% | -1.32% | Upgrade |
Effective Tax Rate | - | - | 161.76% | - | 33.23% | - | Upgrade |
Revenue as Reported | 120.8 | 126.08 | 132.58 | 99.95 | 105.14 | 94.86 | Upgrade |
Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.